HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 82 filers reported holding HARROW HEALTH INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,325 | +31.0% | 20,134 | +73.6% | 0.00% | – |
| Q2 2023 | $220,807 | -69.9% | 11,597 | -66.6% | 0.00% | – |
| Q1 2023 | $734,569 | +387.0% | 34,715 | +239.7% | 0.00% | – |
| Q4 2022 | $150,832 | +1575.9% | 10,219 | +1333.2% | 0.00% | – |
| Q3 2022 | $9,000 | -75.7% | 713 | -85.6% | 0.00% | – |
| Q2 2022 | $37,000 | +8.8% | 4,968 | +0.0% | 0.00% | – |
| Q1 2022 | $34,000 | -12.8% | 4,967 | +11.3% | 0.00% | – |
| Q4 2021 | $39,000 | +457.1% | 4,463 | +466.4% | 0.00% | – |
| Q3 2021 | $7,000 | -76.7% | 788 | -75.2% | 0.00% | – |
| Q2 2021 | $30,000 | -77.6% | 3,178 | -84.0% | 0.00% | – |
| Q1 2021 | $134,000 | +97.1% | 19,811 | +101.6% | 0.00% | – |
| Q4 2020 | $68,000 | +106.1% | 9,828 | +67.9% | 0.00% | – |
| Q3 2020 | $33,000 | -84.1% | 5,852 | -85.3% | 0.00% | – |
| Q2 2020 | $208,000 | +100.0% | 39,912 | +47.0% | 0.00% | – |
| Q1 2020 | $104,000 | +420.0% | 27,152 | +573.1% | 0.00% | – |
| Q1 2019 | $20,000 | – | 4,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
| Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
| Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
| Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
| Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
| BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
| Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
| INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
| Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |